Nebula Research & Development LLC Ultragenyx Pharmaceutical Inc. Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 8,876 shares of RARE stock, worth $338,086. This represents 0.04% of its overall portfolio holdings.
Number of Shares
8,876
Previous 4,221
110.28%
Holding current value
$338,086
Previous $234 Million
59.25%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$382 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$213 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$164 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$104 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$95.7 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.67B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...